Document and Entity Information
v6.14.0.7
Document and Entity Information
9 Months Ended
Sep. 30, 2017
Nov. 10, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name MICRON SOLUTIONS INC /DE/  
Entity Central Index Key 0000819689  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Document Type 10-Q  
Document Period End Date Sep. 30, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   2,833,153dei_EntityCommonStockSharesOutstanding
Trading Symbol micr  

Condensed Consolidated Balance Sheets
v6.14.0.7
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 524,606us-gaap_CashAndCashEquivalentsAtCarryingValue $ 380,381us-gaap_CashAndCashEquivalentsAtCarryingValue
Trade accounts receivable, net of allowance for doubtful accounts of $46,000 at September 30, 2017 and $30,000 at December 31, 2016 2,898,677us-gaap_AccountsReceivableNetCurrent 2,276,608us-gaap_AccountsReceivableNetCurrent
Inventories 3,214,157us-gaap_InventoryNet 3,060,085us-gaap_InventoryNet
Prepaid expenses and other current assets 556,503us-gaap_PrepaidExpenseAndOtherAssetsCurrent 614,362us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 7,193,943us-gaap_AssetsCurrent 6,331,436us-gaap_AssetsCurrent
Property, plant and equipment, net 6,089,496us-gaap_PropertyPlantAndEquipmentNet 6,440,911us-gaap_PropertyPlantAndEquipmentNet
Assets held for sale, net 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup
Intangible assets, net 57,812us-gaap_IntangibleAssetsNetExcludingGoodwill 30,093us-gaap_IntangibleAssetsNetExcludingGoodwill
Other assets 9,146us-gaap_OtherAssetsNoncurrent 156,231us-gaap_OtherAssetsNoncurrent
Total assets 14,039,147us-gaap_Assets 13,647,421us-gaap_Assets
Current liabilities:    
Revolving line of credit 3,070,000micr_RevolvingLineOfCreditCurrentPortion 1,785,795micr_RevolvingLineOfCreditCurrentPortion
Equipment line of credit 504,781micr_EquipmentLineOfCreditCurrentPortionDue 102,500micr_EquipmentLineOfCreditCurrentPortionDue
Term notes payable, current portion 2,093,133micr_TermNotesPayableCurrentPortion 487,468micr_TermNotesPayableCurrentPortion
Accounts payable 1,711,661us-gaap_AccountsPayableCurrent 1,744,261us-gaap_AccountsPayableCurrent
Accrued expenses and other current liabilities 445,338us-gaap_OtherLiabilitiesCurrent 333,361us-gaap_OtherLiabilitiesCurrent
Customer deposits 260,433us-gaap_CustomerDepositsCurrent 122,290us-gaap_CustomerDepositsCurrent
Deferred revenue, current 122,889us-gaap_DeferredRevenueCurrent 224,988us-gaap_DeferredRevenueCurrent
Total current liabilities 8,208,235us-gaap_LiabilitiesCurrent 4,800,663us-gaap_LiabilitiesCurrent
Long-term liabilities:    
Term notes payable, non-current portion   1,970,863micr_TermNotesPayableNonCurrentPortion
Subordinated promissory notes 438,739us-gaap_SubordinatedLongTermDebt 432,011us-gaap_SubordinatedLongTermDebt
Deferred revenue, non-current portion   156,953us-gaap_DeferredRevenueNoncurrent
Total long-term liabilities 438,739us-gaap_LiabilitiesNoncurrent 2,559,827us-gaap_LiabilitiesNoncurrent
Total liabilities 8,646,974us-gaap_Liabilities 7,360,490us-gaap_Liabilities
Commitments and Contingencies      
Shareholders' equity:    
Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued      
Common stock, $0.01 par value; 10,000,000 shares authorized; 3,926,491 issued, 2,833,153 outstanding at September 30, 2017 and 3,926,491 issued, 2,816,639 outstanding at December 31, 2016 39,265us-gaap_CommonStockValue 39,265us-gaap_CommonStockValue
Additional paid-in-capital 11,508,256us-gaap_AdditionalPaidInCapital 11,457,320us-gaap_AdditionalPaidInCapital
Treasury stock at cost, 1,093,338 shares at September 30, 2017 and 1,109,852 shares at December 31, 2016 (2,983,501)us-gaap_TreasuryStockValue (3,028,564)us-gaap_TreasuryStockValue
Accumulated deficit (3,171,847)us-gaap_RetainedEarningsAccumulatedDeficit (2,181,090)us-gaap_RetainedEarningsAccumulatedDeficit
Total shareholders’ equity 5,392,173us-gaap_StockholdersEquity 6,286,931us-gaap_StockholdersEquity
Total liabilities and shareholders’ equity $ 14,039,147us-gaap_LiabilitiesAndStockholdersEquity $ 13,647,421us-gaap_LiabilitiesAndStockholdersEquity

Condensed Consolidated Balance Sheets (Parenthetical)
v6.14.0.7
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2017
Dec. 31, 2016
Condensed Consolidated Balance Sheets [Abstract]    
Allowance for doubtful accounts receivable, current $ 46,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent $ 30,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Preferred stock, par value per share $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
Preferred stock, shares authorized 2,000,000us-gaap_PreferredStockSharesAuthorized 2,000,000us-gaap_PreferredStockSharesAuthorized
Preferred stock, shares issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued
Common stock, par value per share $ 0.01us-gaap_CommonStockParOrStatedValuePerShare $ 0.01us-gaap_CommonStockParOrStatedValuePerShare
Common stock, shares authorized 10,000,000us-gaap_CommonStockSharesAuthorized 10,000,000us-gaap_CommonStockSharesAuthorized
Common stock, shares issued 3,926,491us-gaap_CommonStockSharesIssued 3,926,491us-gaap_CommonStockSharesIssued
Common stock, shares outstanding 2,833,153us-gaap_CommonStockSharesOutstanding 2,816,639us-gaap_CommonStockSharesOutstanding
Treasury stock, shares 1,093,338us-gaap_TreasuryStockShares 1,109,852us-gaap_TreasuryStockShares

Condensed Consolidated Statements of Operations
v6.14.0.7
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Consolidated Statements of Operations [Abstract]        
Net sales $ 4,908,088us-gaap_SalesRevenueNet $ 4,713,123us-gaap_SalesRevenueNet $ 15,563,791us-gaap_SalesRevenueNet $ 14,825,417us-gaap_SalesRevenueNet
Cost of sales 4,215,843us-gaap_CostOfGoodsAndServicesSold 3,902,363us-gaap_CostOfGoodsAndServicesSold 13,836,335us-gaap_CostOfGoodsAndServicesSold 12,384,788us-gaap_CostOfGoodsAndServicesSold
Gross profit 692,245us-gaap_GrossProfit 810,760us-gaap_GrossProfit 1,727,456us-gaap_GrossProfit 2,440,629us-gaap_GrossProfit
Selling and marketing 171,304us-gaap_SellingAndMarketingExpense 303,279us-gaap_SellingAndMarketingExpense 671,997us-gaap_SellingAndMarketingExpense 900,189us-gaap_SellingAndMarketingExpense
General and administrative 614,082us-gaap_GeneralAndAdministrativeExpense 482,115us-gaap_GeneralAndAdministrativeExpense 1,783,590us-gaap_GeneralAndAdministrativeExpense 1,664,182us-gaap_GeneralAndAdministrativeExpense
Research and development 26,787us-gaap_ResearchAndDevelopmentExpense 24,534us-gaap_ResearchAndDevelopmentExpense 84,427us-gaap_ResearchAndDevelopmentExpense 74,792us-gaap_ResearchAndDevelopmentExpense
Total operating expenses 812,173us-gaap_OperatingExpenses 809,928us-gaap_OperatingExpenses 2,540,014us-gaap_OperatingExpenses 2,639,163us-gaap_OperatingExpenses
Net income (loss) from operations (119,928)us-gaap_OperatingIncomeLoss 832us-gaap_OperatingIncomeLoss (812,558)us-gaap_OperatingIncomeLoss (198,534)us-gaap_OperatingIncomeLoss
Other expense:        
Interest expense (83,835)us-gaap_InterestExpense (69,596)us-gaap_InterestExpense (235,165)us-gaap_InterestExpense (193,092)us-gaap_InterestExpense
Other income, net 22,896us-gaap_OtherNonoperatingIncomeExpense 202us-gaap_OtherNonoperatingIncomeExpense 56,966us-gaap_OtherNonoperatingIncomeExpense 1,029us-gaap_OtherNonoperatingIncomeExpense
Total other expense, net (60,939)micr_OtherExpenseNet (69,394)micr_OtherExpenseNet (178,199)micr_OtherExpenseNet (192,063)micr_OtherExpenseNet
Net loss before income tax provision (benefit) (180,867)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (68,562)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (990,757)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (390,597)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax provision (benefit)            
Net loss $ (180,867)us-gaap_NetIncomeLoss $ (68,562)us-gaap_NetIncomeLoss $ (990,757)us-gaap_NetIncomeLoss $ (390,597)us-gaap_NetIncomeLoss
Earnings (loss) per share - basic and diluted $ (0.06)us-gaap_EarningsPerShareBasicAndDiluted $ (0.02)us-gaap_EarningsPerShareBasicAndDiluted $ (0.35)us-gaap_EarningsPerShareBasicAndDiluted $ (0.14)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding - basic and diluted 2,821,263us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 2,816,639us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 2,820,369us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 2,816,475us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Condensed Consolidated Statements of Cash Flows
v6.14.0.7
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (990,757)us-gaap_NetIncomeLoss $ (390,597)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Gain on sale of property, plant and equipment (21,750)us-gaap_GainLossOnSaleOfPropertyPlantEquipment  
Depreciation and amortization 1,208,872us-gaap_DepreciationDepletionAndAmortization 1,152,001us-gaap_DepreciationDepletionAndAmortization
Non-cash interest expense 23,211micr_NonCashInterestExpense 20,762micr_NonCashInterestExpense
Changes in allowance for doubtful accounts 16,000micr_IncreaseDecreaseInAllowanceForDoubtfulAccounts (30,000)micr_IncreaseDecreaseInAllowanceForDoubtfulAccounts
Share-based compensation expense 84,750us-gaap_ShareBasedCompensation 35,083us-gaap_ShareBasedCompensation
Changes in operating assets and liabilities:    
Accounts receivable (638,069)us-gaap_IncreaseDecreaseInAccountsReceivable 460,983us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (154,072)us-gaap_IncreaseDecreaseInInventories (1,025,759)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets 57,860us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (130,953)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Other non-current assets 147,085us-gaap_IncreaseDecreaseInOtherNoncurrentAssets 31,530us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Accounts payable (32,599)us-gaap_IncreaseDecreaseInAccountsPayable 411,278us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses and other current liabilities 123,222us-gaap_IncreaseDecreaseInAccruedLiabilities 83,922us-gaap_IncreaseDecreaseInAccruedLiabilities
Customer deposits 138,143us-gaap_IncreaseDecreaseInCustomerDeposits 298,627us-gaap_IncreaseDecreaseInCustomerDeposits
Deferred revenue, current (102,099)us-gaap_IncreaseDecreaseInDeferredRevenue (19,156)us-gaap_IncreaseDecreaseInDeferredRevenue
Other non-current liabilities (156,953)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities (16,769)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities
Net cash provided by (used in) operating activities (297,156)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 880,952us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Purchases of property, plant and equipment (868,716)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (1,069,325)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of property, plant and equipment 34,600us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment  
Cash paid for patents and trademarks (29,307)micr_CashPaidForPatentsAndTrademarks  
Net cash provided by (used in) investing activities (863,423)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (1,069,325)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Proceeds from (payments on) revolving line of credit, net 1,284,205micr_ProceedsFromPaymentsOnRevolvingLineOfCreditNet 35,000micr_ProceedsFromPaymentsOnRevolvingLineOfCreditNet
Proceeds from equipment line of credit 402,281micr_ProceedsFromEquipmentLineOfCredit 544,851micr_ProceedsFromEquipmentLineOfCredit
Payments on term notes payable (381,682)us-gaap_RepaymentsOfMediumTermNotes (477,900)us-gaap_RepaymentsOfMediumTermNotes
Proceeds from stock option exercises   51,150us-gaap_ProceedsFromStockOptionsExercised
Net cash provided by (used in) financing activities 1,304,804us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 153,101us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase (decrease) in cash and cash equivalents 144,225us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (35,272)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 380,381us-gaap_Cash 272,291us-gaap_Cash
Cash and cash equivalents, end of period 524,606us-gaap_Cash 237,019us-gaap_Cash
Supplemental Cash Flow Information    
Cash paid for interest 202,327us-gaap_InterestPaidNet 173,035us-gaap_InterestPaidNet
Non-cash activities:    
Issuance of Treasury Stock for Directors Fees 58,500us-gaap_StockIssued1  
Equipment line of credit converted to term notes payable   $ 881,701micr_EquipmentLineOfCreditConvertedToTermNotesPayable

Basis of Presentation
v6.14.0.7
Basis of Presentation
9 Months Ended
Sep. 30, 2017
Basis of Presentation [Abstract]  
Basis of Presentation

1.  Basis of Presentation



The consolidated financial statements (the "financial statements") include the accounts of Micron Solutions, Inc.® (“Micron Solutions”) and its subsidiary, Micron Products, Inc.® ("Micron" and together with Micron Solutions, the “Company”).  All intercompany balances and transactions have been eliminated in consolidation.



The unaudited interim condensed consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC").  Accordingly, certain information and footnote disclosures normally included in complete financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been omitted pursuant to such rules and regulations.  These financial statements and related notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 22, 2017.  



The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. The Company's balance sheet at December 31, 2016 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP for complete financial statements.



The information presented reflects, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial results for the interim periods presented. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. 



Recent Accounting Pronouncements



In the normal course of business, management evaluates all new accounting pronouncements issued by the Financial Accounting Standard Board (“FASB”), Securities and Exchange Commission (“SEC”), Emerging Issues Task Force (“EITF”), or other authoritative accounting bodies to determine the potential impact they may have on the Company’s Consolidated Financial Statements. Based upon this review, except as noted below, management does not expect any of the recently issued accounting pronouncements, which have not already been adopted, to have a material impact on the Company’s consolidated financial statements.



ASU No. 2016-02, “Leases (Topic 842)”



In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” which requires companies to recognize all leases as assets and liabilities on the consolidated balance sheet. The standard retains a distinction between finance leases and operating leases, and the classification criteria for distinguishing between finance leases and operating leases are substantially similar to the classification criteria for distinguishing between capital leases and operating leases in the current accounting literature. The result of retaining a distinction between finance leases and operating leases is that under the lessee accounting model in Topic 842, the effect of leases in a consolidated statement of comprehensive income and a consolidated statement of cash flows is largely unchanged from previous GAAP.  The amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Earlier application is permitted.   



As of the date of this report, the Company is the lessee of office equipment in a single operating lease and is the lessee of a parking lot as well as storage units.  The Company is not a lessor in any arrangements.  The Company is evaluating other supplier relationships to determine if such arrangements constitute a lease per this guidance.  The Company expects to complete its evaluation prior to the end of 2017 and will evaluate the impact of adoption at that time.  The Company does not expect any material impact on reporting or on the results of operations. 



ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”)



In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). The core principle behind ASU No. 2014-09 is that an entity should recognize revenue in an amount that reflects the consideration to which the entity expects to be entitled in exchange for delivering goods and services. This model involves a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when the entity satisfies the performance obligations. This ASU allows two methods of adoption; a full retrospective approach where historical financial information is presented in accordance with the new standard, and a modified retrospective approach where this ASU is applied to the most current period presented in the financial statements. In August 2015, the FASB issued ASU No. 2015-14 “Revenue from Contracts with Customers: Deferral of the Effective Date,” which deferred the effective date of ASU 2014-09 to annual reporting periods beginning after December 15, 2017, with earlier application permitted as of annual reporting periods beginning after December 15, 2016.



As of the date of this report the Company has established a multi-disciplinary team including members of executive management, accounting, sales, operations and IT which is began implementation of a transition plan to the new guidance in the third quarter.  The team will evaluate all supply and manufacturing agreements with customers as well as the nature of other arrangements and relationships between the Company and all other customers (“arrangements”), to determine if a contract, as defined by the guidance, exists.  The Company has compiled a preliminary list of agreements and is evaluating them to determine if there is any potential impact to the accounting for the agreements under this guidance.  After evaluating the arrangements, the Company will determine the appropriate treatment for revenue recognition per the guidance compared to the Company’s present revenue recognition policy as outlined in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 22, 2017.  To date, the Company does not expect any material adverse financial impact from the adoption of this standard.



Operating matters and liquidity 



Due to a non-compliance with the debt service coverage ratio covenant at June 30, 2017, the Company and the bank entered into a forbearance agreement on September 29, 2017.  Under the agreement the bank agreed to forbear from collections on all outstanding debt prior to March 31, 2018, provided no further events of default occur, and agreed to extend the revolver to March 31, 2018 subject to certain modifications of the agreement.  Should a further event of default occur, the bank has the right to demand payments of all notes. 

Pursuant to the agreement, the interest rate under the revolver increased from the Prime Rate plus 0.25%, to the Prime Rate plus 1.00%, an increase of 75 basis points.  The Company also agreed to provide monthly financial reporting and daily cash sweeps and to a modification of the equipment line of credit (the “equipment line”) to immediately terminate the availability of further advances under the equipment line rather than expiration thereof in November 2017 at which time the equipment line will convert into a five-year term note.  In addition, the bank agreed to modify the debt service coverage ratio calculation for the September 30, 2017 measurement date.    The Company is in compliance with this revised third quarter 2017 covenant calculation.    Additionally, under the agreement, and in accordance with its rights under subordination agreements between the bank and the Company’s subordinated note holders, the quarterly interest payments to the note holders have been deferred due to previous non-compliance with the debt service coverage ratio covenant until such time as the bank otherwise permits resumption thereof.



The Company is working with its bank under the extended credit facility while exploring alternative financing arrangementsThe Company believes that cash flows from its operations, together with its existing working capital, increased booked orders and other resources, and the expected securing of a new facility will be sufficient to enable the Company to fund operations at current levels and repay debt obligations over the next twelve months; however, there can be no assurance that the Company will be able to do so. 

   

Assessment of going concern 



The Company follows accounting standard ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The accounting standard requires management to evaluate whether there are conditions that give rise to substantial doubt as to the Company’s ability to continue as a going concern within one year from the date of issuance of these financial statements. Substantial doubt exists when conditions and events, considered in the aggregate, indicate that it is probable that a company will be unable to meet its obligations as they become due within one year after the financial statement issuance date. Management evaluations include identifying relevant conditions and events that were known and reasonably knowable as of the date these financial statements have been issued.



At December 31, 2016, the Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s ability to renew the credit facility which was maturing in June 2017, negative financial history and the Company’s limited liquidity to meet the working capital needs to support the Company’s operations.  While the Company was successful in extending the credit facility to March 31, 2018, similar conditions existed as of September 30, 2017. 



As of the June 30, 2017 testing date, the Company was in compliance with the terms of the credit facility except with respect to the debt service coverage ratio covenant.  As a result of the non-compliance, the Company and the bank entered into a forbearance agreement on September 29, 2017.  Under the agreement the bank agreed to forbear from collections on all outstanding debt prior to March 31, 2018 and agreed to extend the revolver to March 31, 2018, subject to certain modifications to the agreement.  These modifications include an increase in interest rates, daily cash sweeps, terminating the availability of further advances under the equipment line and modification of the debt service ratio covenant calculation for the September 30, 2017 measurement date.  The Company is in compliance with this revised third quarter 2017 covenant calculation.



Management’s assessment included an analysis of the Company’s year to date 2017 results and financial forecasts looking forward twelve months from the date of these financial statements. Management’s assessment also considered the Company’s history of meeting financial covenants and being able to renew and refinance its debt obligations.



During the first two quarters of 2017, the Company made strategic decisions to take on new large orders, at aggressive initial pricing, in order to land follow-on orders with lower material costs.  During this period the Company incurred extraordinary costs related to the starting up of these new customers, including increased scrap, tooling, labor, rework, expediting charges from suppliers, shift premiums and overtime, in order to meet customer delivery requirements.  The Company landed the follow-on orders with the lower material costs and mitigated the startup costs of these new products.



The forecasts for the second half of 2017 and 2018 reflect the actual and expected results of cost savings measures and productivity improvements implemented, beginning at the end of the second quarter of 2017.  These include more efficient use of labor by reducing overtime and modifying production schedules, process improvements, improved material yields, and decreased overhead expenses in part by compensation reductions for all salaried personnel including executive officers.  In July 2017, the Company engaged a manufacturing consultancy firm with a focus on plastics, medical devices, contract manufacturing and outsourcing to analyze and benchmark the Company’s operations, suggest business development strategies and improve operating performance. Additionally, in August 2017, the Company engaged an investment banking firm to evaluate the overall strategic direction of the Company.



The implementation of the cost savings measures and improvements yielded results in the third quarter of 2017.  Despite a $482,638 decrease in net sales, gross profit increased $310,408, or 7.0% when compared to the second quarter of 2017.  Further savings in operating expenses also contributed to the improvement in net loss from operations of $434,005 in the second quarter 2017 to a net loss from operations of $42,322, excluding non-recurring charges of $77,606 related to outside efficiency related consulting fees in the third quarter of 2017.  The Company anticipates continued margin improvement and operating results through the fourth quarter and into 2018.  



Management continues to work with its bank under the credit facility, which was extended to March 31, 2018, to further extend the credit facility while also exploring alternative financing arrangements. Based upon the continued results of cost savings measures and improvements as noted above, cash forecasts,  the expected fulfillment of booked orders from existing customers and new customer prospects, and the expected securing of a new credit facility, the Company expects to meet its debt obligations for the next twelve months, however there can be no assurance that the Company will be able to do so.  The financial statements do not include any adjustment that might result from the outcome of such uncertainties.

 


Earnings Per Share (_EPS_)
v6.14.0.7
Earnings Per Share ("EPS")
9 Months Ended
Sep. 30, 2017
Earnings Per Share ("EPS") [Abstract]  
Earnings Per Share ("EPS")

2.  Earnings per Share ("EPS")



Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding.  The computation of diluted earnings (loss) per share is similar to the computation of basic earnings (loss) per share except that the denominator is increased to include the average number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.  In addition, the numerator is adjusted for any changes in net income (loss) that would result from the assumed conversions of those potential shares.    



For the three months ended September 30, 2017 and 2016, basic and diluted earnings per share was a loss of $0.06 per share and a loss of $0.02 per share, respectively.  For the nine months ended September 30, 2017 and 2016, basic and diluted earnings per share was a loss of $0.35 per share and a loss of $0.14 per share, respectively. 

 


Inventories
v6.14.0.7
Inventories
9 Months Ended
Sep. 30, 2017
Inventories [Abstract]  
Inventories

3.  Inventories



Inventories consist of the following:







 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2017

 

2016

Raw materials

 

$

1,060,790 

 

$

1,027,474 

Work-in-process

 

 

672,843 

 

 

537,858 

Finished goods

 

 

1,480,524 

 

 

1,494,753 

Total

 

$

3,214,157 

 

$

3,060,085 



Silver included in raw materials, work-in-process and finished goods inventory had an estimated cost of $506,991 and $521,745 as of September 30, 2017 and December 31, 2016, respectively. 

 


Property, Plant and Equipment, net
v6.14.0.7
Property, Plant and Equipment, net
9 Months Ended
Sep. 30, 2017
Property, Plant and Equipment, net [Abstract]  
Property, Plant and Equipment, net

4.  Property, Plant and Equipment, net



Property, plant and equipment, net consist of the following:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

Asset Lives

 

September 30,

 

December 31,



 

(in years)

 

2017

 

2016

Machinery and equipment

 

3

to

15

 

$

17,423,212 

 

$

16,647,302 

Building and improvements

 

5

to

25

 

 

3,986,715 

 

 

3,986,715 

Vehicles

 

3

to

5

 

 

90,713 

 

 

90,713 

Furniture, fixtures, computers and software

 

3

to

5

 

 

1,538,316 

 

 

1,504,776 

Construction in progress

 

 

 

 

 

 

41,100 

 

 

402,099 

Total property, plant and equipment

 

 

 

 

 

 

23,080,056 

 

 

22,631,605 

Less: accumulated depreciation

 

 

 

 

 

 

(16,990,560)

 

 

(16,190,694)

Property, plant and equipment, net

 

 

 

 

 

$

6,089,496 

 

$

6,440,911 



For the three months ended September 30, 2017 and 2016, the Company recorded depreciation expense of $405,402 and $406,122, respectively.  For the nine months ended September 30, 2017 and 2016, the Company recorded depreciation expense of $1,207,283 and $1,150,683, respectively.

 

In  January 2016, the Company entered into a Purchase and Sale Agreement (the “Agreement)  with a Buyer (collectively the “Parties”) to sell two unoccupied buildings, with approximately 52,000 square feet, and land, at its Fitchburg, Massachusetts campus. 



In December 2016, the Parties entered into a First Amendment to the Agreement (the First Amendment) which extended the time to close to January 13, 2018.   As part of the consideration for extending the Agreement the Buyer agreed to pay certain extension fees.

 

In January 2017, the Parties entered into a Second Amendment to the Agreement (the “Second Amendment”) to further extend the time to close to July 2018.   The Second Amendment permits the Buyer to assign the Agreement to a third party and extends the extension fees through July 2018 or the culmination of the Agreement.



On July 13, 2017, the Parties entered into a Third Amendment to the Agreement (the “Third Amendment”) to further extend the time to close to June 2019.  The Third Amendment permitted the Buyer to contract with outside parties to conduct certain due diligence activities on the property up until August 13, 2017.  Additionally, the Third Amendment further extended the extension fees through June 2019, or the culmination of the Agreement, and allows for the Buyer to defer the last six months of extension fees to be settled at closing.



On September 28, 2017, the Parties entered into a Fourth Amendment to the Agreement (the “Fourth Amendment”) to extend the time allowed to the Buyer to complete due diligence activities on the property from August 13, 2017 until October 13, 2017.



At September 30, 2017 and December 31, 2016, the real estate under agreement was classified as Assets Held for Sale valued at $688,750.  The carrying value approximated the fair value less the cost to sell.

 


Intangible Assets, net
v6.14.0.7
Intangible Assets, net
9 Months Ended
Sep. 30, 2017
Intangible Assets, net [Abstract]  
Intangibles Assets, net

5.  Intangible Assets, net



The Company assesses the impairment of long-lived assets and intangible assets with finite lives annually or whenever events or changes in circumstances indicate that the carrying value may not be fully recoverable. For the three and nine months ended September 30, 2017 and 2016, the Company did not impair any intangible assets. 



Intangible assets consist of the following:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Estimated

 

September 30, 2017

 

December 31, 2016



 

Useful Life

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Accumulated

 

 

 



 

(in years)

 

Gross

 

Amortization

 

Net

 

Gross

 

Amortization

 

Net

Patents and trademarks

 

10 

 

$

26,290 

 

$

11,057 

 

$

15,233 

 

$

26,290 

 

$

9,738 

 

$

16,552 

Patents and trademarks pending

 

 —

 

 

39,581 

 

 

 —

 

 

39,581 

 

 

13,541 

 

 

 —

 

 

13,541 

Trade names

 

 —

 

 

3,268 

 

 

270 

 

 

2,998 

 

 

 —

 

 

 —

 

 

 —

Total intangible assets

 

 

 

$

69,139 

 

$

11,327 

 

$

57,812 

 

$

39,831 

 

$

9,738 

 

$

30,093 



For the three months ended September 30, 2017 and 2016, the Company recorded amortization expense of $602 and $439, respectively.  For the nine months ended September 30, 2017 and 2016, the Company recorded amortization expense of $1,588 and $1,318, respectively.  

 


Debt
v6.14.0.7
Debt
9 Months Ended
Sep. 30, 2017
Debt [Abstract]  
Debt

6.  Debt



The following table sets forth the items which comprise debt for the Company:





 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2017

 

2016

Revolving line of credit

 

$

3,070,000 

 

$

1,785,795 

Equipment line of credit

 

$

504,781 

 

$

102,500 

Subordinated promissory notes

 

$

438,739 

 

$

432,011 



 

 

 

 

 

 

Term notes payable:

 

 

 

 

 

 

Commercial term loan

 

$

2,078,006 

 

$

2,398,870 

Equipment notes

 

 

15,127 

 

 

59,461 

Total term notes payable

 

$

2,093,133 

 

$

2,458,331 



 

 

 

 

 

 

Total Debt

 

$

6,106,653 

 

$

4,778,637 



Bank Debt



The Company has a multi-year credit facility with a Massachusetts based bank.  This credit facility consists of a revolving line of credit (the "revolver"), a commercial term loan and an equipment line of credit (“equipment line”).  The debt is secured by substantially all assets of the Company with the exception of real property.  



Due to a non-compliance with the debt service coverage ratio covenant at June 30, 2017, the Company and the bank entered into a forbearance agreement on September 29, 2017.  Under the agreement the bank agreed to forbear from collections on all outstanding debt prior to March 31, 2018, provided no further events of default occur, and agreed to extend the revolver to March 31, 2018 subject to certain modifications of the agreement.  Should a further event of default occur, the bank has the right to demand payments of all notes. 

Pursuant to the agreement, the interest rate under the revolver increased from the Prime Rate plus 0.25%, to the Prime Rate plus 1.00%, an increase of 75 basis points.  The Company also agreed to provide monthly financial reporting and daily cash sweeps and to a  modification of the equipment line to immediately terminate the availability of further advances under the equipment line rather than expiration thereof in November 2017 at which time the equipment line will convert into a five-year term note.  In addition, the bank agreed to modify the debt service coverage ratio calculation for the September 30, 2017 measurement date.  The Company is in compliance with this revised third quarter covenant calculation.  As a result of having entered into the agreement, all of the Company’s bank debt has been classified as current liabilities as of September 30, 2017. 



Revolver



The revolver provides for borrowings up to 80% of eligible accounts receivable and 50% of eligible raw materials inventory.  The interest rate on the revolver is calculated at the bank's prime rate plus 1.00%  (5.25% at September 30, 2017).  Amounts available to borrow under the revolver are $95,767 at September 30, 2017.



Commercial term loan



In November 2016, the Company refinanced its bank term debt, including the commercial term loan and three equipment term loans, along with $500,000 from the revolver, into a new $2,481,943 consolidated five year commercial term loan with a maturity date in November 2021.  The interest rate on the loan is a fixed 4.65% per annum and the loan requires monthly payments of principal and interest of approximately $46,500.



Equipment line of credit



In November 2016, the Company entered into the equipment line that allows for advances of up to $1.0 million under the Company's multi-year credit facility. The term of this equipment line is six years, maturing in November 2022, inclusive of a maximum one-year draw period. Repayment shall consist of monthly interest only payments, equal to the bank's prime rate plus 0.25% as to each advance commencing on the date of the loan through the earlier of: (i) one year from the date of the loan or (ii) the date upon which the equipment line is fully advanced (the “Conversion Date”). On the Conversion Date, principal and interest payments will be due and payable monthly in an amount sufficient to pay the loan in full based upon an amortization schedule commensurate with the remaining term of the loan.



Pursuant to the Company’s September 29, 2017 agreement with the bank, the bank terminated the availability of further advances under the equipment line rather than the expiration thereof in November 2017 at which time the equipment line will convert into a five-year term note.    At September 30, 2017, $504,781 has been drawn on the equipment line.  At December 31, 2016, $102,500 had been drawn on the equipment line.



Debt issuance costs



The amount of the commercial term loan presented in the table above is net of debt issuance costs of $29,374 and $45,858 at September 30, 2017 and December 31, 2016, respectively.



Bank covenants



The credit facility contains both financial and non-financial covenants. The financial covenants include maintaining certain debt service coverage and leverage ratios. The non-financial covenants relate to various matters including notice prior to executing further borrowings and security interests, mergers or consolidations, acquisitions, guarantees, sales of assets other than in the normal course of business, leasing, changes in ownership and payment of dividends. 



As of the June 30, 2017 testing date, the Company was in compliance with the terms of the credit facility except with respect to the debt service coverage ratio covenant.  As a result of the non-compliance, the Company entered into the September 29, 2017 agreement with the bank whereby, among other things, the bank agreed to forbear collections of all outstanding debt prior to March 31, 2018.  In addition, the bank agreed to modify the debt service coverage ratio calculation for the September 30, 2017 measurement date.    The Company is in compliance with this revised third quarter covenant calculation.



Other Debt



Equipment notes



In January 2013, the Company entered into two equipment notes totaling $272,500 with a financing company to acquire production equipment. The notes bear interest at the fixed rate of 4.66% and require monthly payments of principal and interest of approximately $5,000 over a five year term maturing in January 2018.



Subordinated promissory notes



In December 2013, the Company completed a private offering in which the Company sold an aggregate of $500,000 in subordinated promissory notes. The unsecured notes required quarterly interest-only payments at a rate of 10% per annum for the first two years.  In December 2015, the interest rate increased to 12% per annum.  Three related parties participated in the private offering as follows:  REF Securities, LLP, and with Mr. Rodd E. Friedman, a director of the Company since July 21, 2017, a  beneficial owner of approximately 13% of the Company’s common stock, invested $100,000 in the offering; the Chambers Medical Foundation (the “Foundation”), beneficial owner of approximately 10% of the Company’s common stock, invested $100,000 in the offering; and Mr. E.P. Marinos, a director, invested $50,000 in the offering.  The Company’s Chairman of the Board is a co-trustee of the Foundation but has held no dispositive powers since his appointment as such. 

 

In October 2016, the Company and six of the seven investors in the private offering, aggregating $450,000 of the notes, including the three related parties holding $250,000 of the notes, agreed to extend the maturity dates of the notes to December 31, 2018 at a rate of 10% per annum.  One investor did not extend the maturity date and that $50,000 note was paid at maturity in December 2016.  The notes are subordinated to all indebtedness of the Company pursuant to its multi-year bank credit facility. Pursuant to the subordination agreements entered into among the bank, each of the note holders, and the Company upon issuance of the subordinated notes, quarterly interest payments to the note holders have been deferred due to the non-compliance with the debt service coverage ratio covenant until such time as the bank otherwise permits resumption thereof.



In connection with the subordinated promissory notes, the Company issued 100,000 warrants to purchase the Company's common stock, including 20,000 warrants to REF Securities, LLP, 20,000 warrants to the Foundation and 10,000 warrants to Mr. Marinos.  The warrants were exercisable through December 2016 at an exercise price of $3.51 per share.  In 2014, 30,000 warrants were exercised, including 20,000 by the Foundation.  In October 2016, in connection with the extension of the maturity dates of the subordinated promissory notes, the expiration date of the remaining 70,000 warrants was extended to December 31, 2018.  The exercise price remained unchanged at $3.51 per share.  The 70,000 warrants remain unexercised at September 30, 2017.



In the fourth quarter of 2016, the Company calculated the incremental fair value of extending the expiration date of the Notes and Warrants and determined that the amendment represented a debt modification in accordance with the guidance outlined in ASC-470, “Debt”.  Using the Black-Scholes model, and the 10% test, the Company determined that the incremental fair value of the warrants to be $18,310 which was recorded as a reduction against the Notes and an increase in Additional Paid-in Capital. 



The discount on the notes is being recognized as non-cash interest expense over the term of the notes. The Company recorded $2,218 and $6,727 for the three months ended September 30, 2017 and 2016,  and $6,921 and $20,763 for the nine months ended September 30, 2017 and 2016, respectively.    



The unamortized discount which is net against the outstanding balance of the subordinated promissory notes is $11,261 at September 30, 2017 and $17,989 at December 31, 2016.

 


Income Taxes
v6.14.0.7
Income Taxes
9 Months Ended
Sep. 30, 2017
Income Taxes [Abstract]  
Income Taxes

7.  Income Taxes



No provision for income taxes has been recorded in the three or nine months ended September 30, 2017 or 2016, respectively.    The Company has a full valuation allowance against its deferred tax assets as of September 30, 2017 and December 31, 2016. 



At September 30, 2017, the Company has federal and state net operating loss carryforwards totaling $9,124,000 and $8,196,000, respectively, which begin to expire in 2030. The Company also has federal and state tax credit carryovers of $303,000 and $357,000 respectively. The federal and state tax credits begin to expire in 2026 and 2027, respectively. 

 


Commitments and Contingencies
v6.14.0.7
Commitments and Contingencies
9 Months Ended
Sep. 30, 2017
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

8.  Commitments and Contingencies



Legal matters



In the ordinary course of its business, the Company is involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material impact on the Company’s financial position or results of operations.



Off-balance sheet arrangements



Lease expense under all operating leases was approximately $4,615 for the three months ended September 30, 2017 and 2016, respectively, and $13,114 and $14,444 for the nine months ended September 30, 2017 and 2016, respectively.    




Shareholders' Equity
v6.14.0.7
Shareholders' Equity
9 Months Ended
Sep. 30, 2017
Shareholders' Equity [Abstract]  
Shareholders' Equity

9.  Shareholders’ Equity



Stock options and share-based incentive plan



The following table sets forth the stock option transactions for the nine months ended September 30, 2017:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Weighted

 

 

 



 

 

 

Weighted

 

average

 

 

 



 

 

 

Average

 

remaining

 

Aggregate



 

Number of

 

Exercise

 

contractual

 

Intrinsic



 

options

 

Price

 

term (in years)

 

Value

Outstanding at December 31, 2016

 

214,500 

 

$

5.96 

 

7.12 

 

$

17,340 

Granted

 

 —

 

 

 —

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

Forfeited

 

(7,000)

 

 

4.26 

 

 

 

 

 

Expired

 

(2,000)

 

 

3.67 

 

 

 

 

 

Outstanding at September 30, 2017

 

205,500 

 

$

6.04 

 

6.33 

 

$

28,750 

Exercisable at September 30, 2017

 

115,495 

 

$

6.88 

 

5.93 

 

$

17,980 

Exercisable at December 31, 2016

 

109,495 

 

$

6.90 

 

5.47 

 

$

8,880 



For the three months ended September 30, 2017 and 2016, share based compensation expense related to stock options amounted to $5,083 and $4,492, respectively.  For the nine months ended September 30, 2017 and 2016, share-based compensation expense related to stock options amounted to $26,250 and $35,083, respectively.  Share based compensation is included in general and administrative expenses.



For the three months ended September 30, 2017, no options were granted or exercised, 3,000 options were forfeited and 2,000 options expired due to employee terminations.  For the three months ended September 30, 2016, no options were granted, exercised,  forfeited or expired



For the nine months ended September 30, 2017, no options were granted or exercised, 7,000 options were forfeited and 2,000 options expired due to employee terminations.  For the nine months ended September 30, 2016, 5,000 options were granted and 15,000 options were exercised generating proceeds of $51,150.    



Warrants



For the three months ended September 30, 2017 and 2016, there were no warrants exercised. As of September 30, 2017,  70,000 warrants remain unexercised, including 20,000 held by the Company’s largest beneficial owner, REF Securities, LLP and with Mr. Rodd E. Friedman, a director of the Company, and 10,000 held by Mr. E. P. Marinos, a director of the Company.  The warrants expire in December 2018.



Common Stock



For the three months ended September 30, 2017, the Company issued 12,154 shares of the Company’s common stock, pursuant to the 2010 Equity Incentive Plan, with a fair value of $47,250 for director fees in lieu of cash payments.  For the three months ended September 30, 2016, there were no such stock grants.



For the nine months ended September 30, 2017, the Company issued 16,514 shares of the Company’s common stock, pursuant to the 2010 Equity Incentive Plan, with a fair value of $58,500 for director fees in lieu of cash payments.  For the nine months ended September 30, 2016, there were no such stock grants.

 


Basis of Presentation (Policies)
v6.14.0.7
Basis of Presentation (Policies)
9 Months Ended
Sep. 30, 2017
Accounting Policies [Abstract]  
Recently Accounting Pronouncements

Recent Accounting Pronouncements



In the normal course of business, management evaluates all new accounting pronouncements issued by the Financial Accounting Standard Board (“FASB”), Securities and Exchange Commission (“SEC”), Emerging Issues Task Force (“EITF”), or other authoritative accounting bodies to determine the potential impact they may have on the Company’s Consolidated Financial Statements. Based upon this review, except as noted below, management does not expect any of the recently issued accounting pronouncements, which have not already been adopted, to have a material impact on the Company’s consolidated financial statements.



ASU No. 2016-02, “Leases (Topic 842)”



In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” which requires companies to recognize all leases as assets and liabilities on the consolidated balance sheet. The standard retains a distinction between finance leases and operating leases, and the classification criteria for distinguishing between finance leases and operating leases are substantially similar to the classification criteria for distinguishing between capital leases and operating leases in the current accounting literature. The result of retaining a distinction between finance leases and operating leases is that under the lessee accounting model in Topic 842, the effect of leases in a consolidated statement of comprehensive income and a consolidated statement of cash flows is largely unchanged from previous GAAP.  The amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Earlier application is permitted.   



As of the date of this report, the Company is the lessee of office equipment in a single operating lease and is the lessee of a parking lot as well as storage units.  The Company is not a lessor in any arrangements.  The Company is evaluating other supplier relationships to determine if such arrangements constitute a lease per this guidance.  The Company expects to complete its evaluation prior to the end of 2017 and will evaluate the impact of adoption at that time.  The Company does not expect any material impact on reporting or on the results of operations. 



ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”)



In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). The core principle behind ASU No. 2014-09 is that an entity should recognize revenue in an amount that reflects the consideration to which the entity expects to be entitled in exchange for delivering goods and services. This model involves a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when the entity satisfies the performance obligations. This ASU allows two methods of adoption; a full retrospective approach where historical financial information is presented in accordance with the new standard, and a modified retrospective approach where this ASU is applied to the most current period presented in the financial statements. In August 2015, the FASB issued ASU No. 2015-14 “Revenue from Contracts with Customers: Deferral of the Effective Date,” which deferred the effective date of ASU 2014-09 to annual reporting periods beginning after December 15, 2017, with earlier application permitted as of annual reporting periods beginning after December 15, 2016.



As of the date of this report the Company has established a multi-disciplinary team including members of executive management, accounting, sales, operations and IT which is began implementation of a transition plan to the new guidance in the third quarter.  The team will evaluate all supply and manufacturing agreements with customers as well as the nature of other arrangements and relationships between the Company and all other customers (“arrangements”), to determine if a contract, as defined by the guidance, exists.  The Company has compiled a preliminary list of agreements and is evaluating them to determine if there is any potential impact to the accounting for the agreements under this guidance.  After evaluating the arrangements, the Company will determine the appropriate treatment for revenue recognition per the guidance compared to the Company’s present revenue recognition policy as outlined in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 22, 2017.  To date, the Company does not expect any material adverse financial impact from the adoption of this standard.

Operating Matters And Liquidity

Operating matters and liquidity 



Due to a non-compliance with the debt service coverage ratio covenant at June 30, 2017, the Company and the bank entered into a forbearance agreement on September 29, 2017.  Under the agreement the bank agreed to forbear from collections on all outstanding debt prior to March 31, 2018, provided no further events of default occur, and agreed to extend the revolver to March 31, 2018 subject to certain modifications of the agreement.  Should a further event of default occur, the bank has the right to demand payments of all notes. 

Pursuant to the agreement, the interest rate under the revolver increased from the Prime Rate plus 0.25%, to the Prime Rate plus 1.00%, an increase of 75 basis points.  The Company also agreed to provide monthly financial reporting and daily cash sweeps and to a modification of the equipment line of credit (the “equipment line”) to immediately terminate the availability of further advances under the equipment line rather than expiration thereof in November 2017 at which time the equipment line will convert into a five-year term note.  In addition, the bank agreed to modify the debt service coverage ratio calculation for the September 30, 2017 measurement date.    The Company is in compliance with this revised third quarter 2017 covenant calculation.    Additionally, under the agreement, and in accordance with its rights under subordination agreements between the bank and the Company’s subordinated note holders, the quarterly interest payments to the note holders have been deferred due to previous non-compliance with the debt service coverage ratio covenant until such time as the bank otherwise permits resumption thereof.



Assessment Of Going Concern

Assessment of going concern 



The Company follows accounting standard ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The accounting standard requires management to evaluate whether there are conditions that give rise to substantial doubt as to the Company’s ability to continue as a going concern within one year from the date of issuance of these financial statements. Substantial doubt exists when conditions and events, considered in the aggregate, indicate that it is probable that a company will be unable to meet its obligations as they become due within one year after the financial statement issuance date. Management evaluations include identifying relevant conditions and events that were known and reasonably knowable as of the date these financial statements have been issued.



At December 31, 2016, the Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s ability to renew the credit facility which was maturing in June 2017, negative financial history and the Company’s limited liquidity to meet the working capital needs to support the Company’s operations.  While the Company was successful in extending the credit facility to March 31, 2018, similar conditions existed as of September 30, 2017. 



As of the June 30, 2017 testing date, the Company was in compliance with the terms of the credit facility except with respect to the debt service coverage ratio covenant.  As a result of the non-compliance, the Company and the bank entered into a forbearance agreement on September 29, 2017.  Under the agreement the bank agreed to forbear from collections on all outstanding debt prior to March 31, 2018 and agreed to extend the revolver to March 31, 2018, subject to certain modifications to the agreement.  These modifications include an increase in interest rates, daily cash sweeps, terminating the availability of further advances under the equipment line and modification of the debt service ratio covenant calculation for the September 30, 2017 measurement date.  The Company is in compliance with this revised third quarter 2017 covenant calculation.



Management’s assessment included an analysis of the Company’s year to date 2017 results and financial forecasts looking forward twelve months from the date of these financial statements. Management’s assessment also considered the Company’s history of meeting financial covenants and being able to renew and refinance its debt obligations.



During the first two quarters of 2017, the Company made strategic decisions to take on new large orders, at aggressive initial pricing, in order to land follow-on orders with lower material costs.  During this period the Company incurred extraordinary costs related to the starting up of these new customers, including increased scrap, tooling, labor, rework, expediting charges from suppliers, shift premiums and overtime, in order to meet customer delivery requirements.  The Company landed the follow-on orders with the lower material costs and mitigated the startup costs of these new products.



The forecasts for the second half of 2017 and 2018 reflect the actual and expected results of cost savings measures and productivity improvements implemented, beginning at the end of the second quarter of 2017.  These include more efficient use of labor by reducing overtime and modifying production schedules, process improvements, improved material yields, and decreased overhead expenses in part by compensation reductions for all salaried personnel including executive officers.  In July 2017, the Company engaged a manufacturing consultancy firm with a focus on plastics, medical devices, contract manufacturing and outsourcing to analyze and benchmark the Company’s operations, suggest business development strategies and improve operating performance. Additionally, in August 2017, the Company engaged an investment banking firm to evaluate the overall strategic direction of the Company.



The implementation of the cost savings measures and improvements yielded results in the third quarter of 2017.  Despite a $482,638 decrease in net sales, gross profit increased $310,408, or 7.0% when compared to the second quarter of 2017.  Further savings in operating expenses also contributed to the improvement in net loss from operations of $434,005 in the second quarter 2017 to a net loss from operations of $42,322, excluding non-recurring charges of $77,606 related to outside efficiency related consulting fees in the third quarter of 2017.  The Company anticipates continued margin improvement and operating results through the fourth quarter and into 2018.  



Management continues to work with its bank under the credit facility, which was extended to March 31, 2018, to further extend the credit facility while also exploring alternative financing arrangements. Based upon the continued results of cost savings measures and improvements as noted above, cash forecasts,  the expected fulfillment of booked orders from existing customers and new customer prospects, and the expected securing of a new credit facility, the Company expects to meet its debt obligations for the next twelve months, however there can be no assurance that the Company will be able to do so.  The financial statements do not include any adjustment that might result from the outcome of such uncertainties.


Inventories (Tables)
v6.14.0.7
Inventories (Tables)
9 Months Ended
Sep. 30, 2017
Inventories [Abstract]  
Inventories



 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2017

 

2016

Raw materials

 

$

1,060,790 

 

$

1,027,474 

Work-in-process

 

 

672,843 

 

 

537,858 

Finished goods

 

 

1,480,524 

 

 

1,494,753 

Total

 

$

3,214,157 

 

$

3,060,085 




Property, Plant and Equipment, net (Tables)
v6.14.0.7
Property, Plant and Equipment, net (Tables)
9 Months Ended
Sep. 30, 2017
Property, Plant and Equipment, net [Abstract]  
Property, Plant and Equipment, net



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

Asset Lives

 

September 30,

 

December 31,



 

(in years)

 

2017

 

2016

Machinery and equipment

 

3

to

15

 

$

17,423,212 

 

$

16,647,302 

Building and improvements

 

5

to

25

 

 

3,986,715 

 

 

3,986,715 

Vehicles

 

3

to

5

 

 

90,713 

 

 

90,713 

Furniture, fixtures, computers and software

 

3

to

5

 

 

1,538,316 

 

 

1,504,776 

Construction in progress

 

 

 

 

 

 

41,100 

 

 

402,099 

Total property, plant and equipment

 

 

 

 

 

 

23,080,056 

 

 

22,631,605 

Less: accumulated depreciation

 

 

 

 

 

 

(16,990,560)

 

 

(16,190,694)

Property, plant and equipment, net

 

 

 

 

 

$

6,089,496 

 

$

6,440,911 




Intangible Assets, net (Tables)
v6.14.0.7
Intangible Assets, net (Tables)
9 Months Ended
Sep. 30, 2017
Intangible Assets, net [Abstract]  
Intangibles Assets



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Estimated

 

September 30, 2017

 

December 31, 2016



 

Useful Life

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Accumulated

 

 

 



 

(in years)

 

Gross

 

Amortization

 

Net

 

Gross

 

Amortization

 

Net

Patents and trademarks

 

10 

 

$

26,290 

 

$

11,057 

 

$

15,233 

 

$

26,290 

 

$

9,738 

 

$

16,552 

Patents and trademarks pending

 

 —

 

 

39,581 

 

 

 —

 

 

39,581 

 

 

13,541 

 

 

 —

 

 

13,541 

Trade names

 

 —

 

 

3,268 

 

 

270 

 

 

2,998 

 

 

 —

 

 

 —

 

 

 —

Total intangible assets

 

 

 

$

69,139 

 

$

11,327 

 

$

57,812 

 

$

39,831 

 

$

9,738 

 

$

30,093 




Debt (Tables)
v6.14.0.7
Debt (Tables)
9 Months Ended
Sep. 30, 2017
Debt [Abstract]  
Summary of Debt



 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2017

 

2016

Revolving line of credit

 

$

3,070,000 

 

$

1,785,795 

Equipment line of credit

 

$

504,781 

 

$

102,500 

Subordinated promissory notes

 

$

438,739 

 

$

432,011 



 

 

 

 

 

 

Term notes payable:

 

 

 

 

 

 

Commercial term loan

 

$

2,078,006 

 

$

2,398,870 

Equipment notes

 

 

15,127 

 

 

59,461 

Total term notes payable

 

$

2,093,133 

 

$

2,458,331 



 

 

 

 

 

 

Total Debt

 

$

6,106,653 

 

$

4,778,637 




Shareholders' Equity (Tables)
v6.14.0.7
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Shareholders' Equity [Abstract]  
Stock Option Transactions



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Weighted

 

 

 



 

 

 

Weighted

 

average

 

 

 



 

 

 

Average

 

remaining

 

Aggregate



 

Number of

 

Exercise

 

contractual

 

Intrinsic



 

options

 

Price

 

term (in years)

 

Value

Outstanding at December 31, 2016

 

214,500 

 

$

5.96 

 

7.12 

 

$

17,340 

Granted

 

 —

 

 

 —

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

Forfeited

 

(7,000)

 

 

4.26 

 

 

 

 

 

Expired

 

(2,000)

 

 

3.67 

 

 

 

 

 

Outstanding at September 30, 2017

 

205,500 

 

$

6.04 

 

6.33 

 

$

28,750 

Exercisable at September 30, 2017

 

115,495 

 

$

6.88 

 

5.93 

 

$

17,980 

Exercisable at December 31, 2016

 

109,495 

 

$

6.90 

 

5.47 

 

$

8,880 




Basis of Presentation (Details)
v6.14.0.7
Basis of Presentation (Details) (USD $)
3 Months Ended 9 Months Ended 0 Months Ended
Sep. 30, 2017
Jun. 30, 2017
Sep. 30, 2017
Sep. 29, 2017
Sep. 28, 2017
Line of Credit Facility [Line Items]          
(Decrease) in net sales $ (482,638)micr_IncreaseDecreaseInNetSales        
Increase in gross profit 310,408micr_IncreaseDecreaseInGrossProfit        
Percent of gross profit increase 7.00%micr_PercentOfGrossProfitIncreaseDecrease        
Net loss from operations, excluding non-recurring charge 42,322micr_OperatingIncomeLossExcludingNonRecurringCharge 434,005micr_OperatingIncomeLossExcludingNonRecurringCharge      
Non-recurring charges $ 77,606us-gaap_OtherNonrecurringExpense        
Revolving Credit Facility [Member]          
Line of Credit Facility [Line Items]          
Line of credit, maturity date     Mar. 31, 2018    
Revolving Credit Facility [Member] | Prime Rate [Member]          
Line of Credit Facility [Line Items]          
Basis spread on variable rate       1.00%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
0.25%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
Basis spread on variable rate increase       0.75%micr_DebtInstrumentBasisSpreadOnVariableRateIncreaseDecrease
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
 
Equipment Term Loan 2017 [Member]          
Line of Credit Facility [Line Items]          
Debt instrument, term     5 years    

Earnings Per Share (_EPS_) (Details)
v6.14.0.7
Earnings Per Share ("EPS") (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Earnings Per Share ("EPS") [Abstract]        
Earnings (loss) per share - basic and diluted $ (0.06)us-gaap_EarningsPerShareBasicAndDiluted $ (0.02)us-gaap_EarningsPerShareBasicAndDiluted $ (0.35)us-gaap_EarningsPerShareBasicAndDiluted $ (0.14)us-gaap_EarningsPerShareBasicAndDiluted

Inventories (Details)
v6.14.0.7
Inventories (Details) (USD $)
Sep. 30, 2017
Dec. 31, 2016
Inventories [Abstract]    
Raw materials $ 1,060,790us-gaap_InventoryRawMaterialsNetOfReserves $ 1,027,474us-gaap_InventoryRawMaterialsNetOfReserves
Work-in-process 672,843us-gaap_InventoryWorkInProcessNetOfReserves 537,858us-gaap_InventoryWorkInProcessNetOfReserves
Finished goods 1,480,524us-gaap_InventoryFinishedGoodsNetOfReserves 1,494,753us-gaap_InventoryFinishedGoodsNetOfReserves
Total 3,214,157us-gaap_InventoryNet 3,060,085us-gaap_InventoryNet
Silver inventory $ 506,991micr_SilverInventory $ 521,745micr_SilverInventory

Property, Plant and Equipment, net (Narrative) (Details)
v6.14.0.7
Property, Plant and Equipment, net (Narrative) (Details) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2016
item
sqft
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Property, Plant and Equipment, net [Abstract]            
Depreciation expense   $ 405,402us-gaap_Depreciation $ 406,122us-gaap_Depreciation $ 1,207,283us-gaap_Depreciation $ 1,150,683us-gaap_Depreciation  
Number of unoccupied buildings with letter of intent to sale 2micr_NumberOfUnoccupiedBuildingsWithLetterOfIntentToSale          
Area of building 52,000us-gaap_AreaOfRealEstateProperty          
Assets held for sale, net   $ 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup   $ 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup   $ 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup

Property, Plant and Equipment, net (Property, Plant and Equipment, net) (Details)
v6.14.0.7
Property, Plant and Equipment, net (Property, Plant and Equipment, net) (Details) (USD $)
9 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Property, Plant and Equipment    
Total property, plant and equipment 23,080,056us-gaap_PropertyPlantAndEquipmentGross $ 22,631,605us-gaap_PropertyPlantAndEquipmentGross
Less: accumulated depreciation (16,990,560)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment (16,190,694)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
Property, plant and equipment, net 6,089,496us-gaap_PropertyPlantAndEquipmentNet 6,440,911us-gaap_PropertyPlantAndEquipmentNet
Machinery and Equipment [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 17,423,212us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_MachineryAndEquipmentMember
16,647,302us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_MachineryAndEquipmentMember
Building and Improvements [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 3,986,715us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
3,986,715us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
Vehicles [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 90,713us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_VehiclesMember
90,713us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_VehiclesMember
Furniture, Fixtures, Computers and Software [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 1,538,316us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
1,504,776us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
Construction in Progress [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 41,100us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_ConstructionInProgressMember
$ 402,099us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_ConstructionInProgressMember
Maximum [Member] | Machinery and Equipment [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 15 years  
Maximum [Member] | Building and Improvements [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 25 years  
Maximum [Member] | Vehicles [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Maximum [Member] | Furniture, Fixtures, Computers and Software [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Minimum [Member] | Machinery and Equipment [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  
Minimum [Member] | Building and Improvements [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Minimum [Member] | Vehicles [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  
Minimum [Member] | Furniture, Fixtures, Computers and Software [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  

Intangible Assets, net (Narrative) (Details)
v6.14.0.7
Intangible Assets, net (Narrative) (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Intangible Assets, net [Abstract]        
Intangible asset impairment $ 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived $ 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived $ 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived $ 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Amortization expense $ 602us-gaap_AmortizationOfIntangibleAssets $ 439us-gaap_AmortizationOfIntangibleAssets $ 1,588us-gaap_AmortizationOfIntangibleAssets $ 1,318us-gaap_AmortizationOfIntangibleAssets

Intangible Assets, net (Intangible Assets) (Details)
v6.14.0.7
Intangible Assets, net (Intangible Assets) (Details) (USD $)
9 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Intangible Assets [Line Items]    
Gross $ 69,139us-gaap_FiniteLivedIntangibleAssetsGross $ 39,831us-gaap_FiniteLivedIntangibleAssetsGross
Accumulated Amortization 11,327us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization 9,738us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Net 57,812us-gaap_FiniteLivedIntangibleAssetsNet 30,093us-gaap_FiniteLivedIntangibleAssetsNet
Patents and Trademarks [Member]    
Intangible Assets [Line Items]    
Estimated Useful Life (in years) 10 years  
Gross 26,290us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
26,290us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Accumulated Amortization 11,057us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
9,738us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Net 15,233us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
16,552us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Patents and Trademarks Pending    
Intangible Assets [Line Items]    
Gross 39,581us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
13,541us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
Net 39,581us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
13,541us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
Trade Names [Member]    
Intangible Assets [Line Items]    
Gross 3,268us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TradeNamesMember
  
Accumulated Amortization 270us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TradeNamesMember
  
Net $ 2,998us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TradeNamesMember
  

Debt (Bank Debt Narrative) (Details)
v6.14.0.7
Debt (Bank Debt Narrative) (Details) (USD $)
1 Months Ended 9 Months Ended
Nov. 30, 2016
Sep. 30, 2017
Dec. 31, 2016
Debt Instrument [Line Items]      
Outstanding balance, line of credit   $ 3,070,000us-gaap_LineOfCredit $ 1,785,795us-gaap_LineOfCredit
Revolving Credit Facility [Member]      
Debt Instrument [Line Items]      
Amount refinanced into new debt instrument 500,000micr_AmountRefinancedIntoNewDebtInstrument
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
   
Percent borrowable of net eligible receivable   80.00%micr_PercentBorrowableOfNetEligibleReceivableRevolvingLoan
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Percent Borrowable of net Eligible Raw Materials Inventory   50.00%micr_PercentBorrowableOfNetEligibleRawMaterialsInventoryRevolvingLoan
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Revolver, interest rate at end of period   5.25%us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Amount available under line of credit facility   95,767us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Line of Credit Facility, Expiration Date   Mar. 31, 2018  
Revolving Credit Facility [Member] | Prime Rate [Member]      
Debt Instrument [Line Items]      
Spread on variable rate   1.00%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
 
Equipment Line of Credit [Member]      
Debt Instrument [Line Items]      
Number of debt instruments converted during period 3micr_NumberOfDebtInstrumentsConvertedDuringPeriod
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
   
Commercial Term Loan [Member]      
Debt Instrument [Line Items]      
Debt instrument, interest rate 4.65%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt maturity period   5 years  
Approximate monthly principal and interest payment 46,500us-gaap_DebtInstrumentPeriodicPayment
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt instrument, face amount 2,481,943us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt issuance costs   29,374us-gaap_DeferredFinanceCostsNet
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
45,858us-gaap_DeferredFinanceCostsNet
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
Equipment Term Loan 2016 [Member] | Equipment Line of Credit [Member]      
Debt Instrument [Line Items]      
Line of credit, draw period   1 year  
Maximum borrowing capacity 1,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
   
Outstanding balance, line of credit   $ 504,781us-gaap_LineOfCredit
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
$ 102,500us-gaap_LineOfCredit
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
Line of credit, maturity period   6 years  
Earliest repayment period, from date of loan   1 year  
Equipment Term Loan 2016 [Member] | Equipment Line of Credit [Member] | Prime Rate [Member]      
Debt Instrument [Line Items]      
Spread on variable rate   0.25%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
 
Equipment Term Loan 2017 [Member]      
Debt Instrument [Line Items]      
Debt maturity period   5 years  

Debt (Other Debt Narrative) (Details)
v6.14.0.7
Debt (Other Debt Narrative) (Details) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2014
Jan. 31, 2013
item
Dec. 31, 2016
item
Oct. 31, 2016
item
Dec. 31, 2015
Dec. 31, 2013
Debt Instruments [Line Items]                    
Number of warrants issued 100,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights   100,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights              
Warrants unexercised 70,000us-gaap_ClassOfWarrantOrRightOutstanding   70,000us-gaap_ClassOfWarrantOrRightOutstanding              
Non-cash interest expense $ 2,218us-gaap_AmortizationOfDebtDiscountPremium $ 6,727us-gaap_AmortizationOfDebtDiscountPremium $ 6,921us-gaap_AmortizationOfDebtDiscountPremium $ 20,763us-gaap_AmortizationOfDebtDiscountPremium            
Subordinated promissory notes, exercise price of warrants             $ 3.51us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1      
REF Securities, LLP & Mr. Rodd E. Friedman [Member]                    
Debt Instruments [Line Items]                    
Number of warrants issued 20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
  20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
             
Warrants unexercised 20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
  20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
             
Chambers Medical Foundation [Member]                    
Debt Instruments [Line Items]                    
Number of warrants issued 20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
  20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
             
Issuance of common stock from treasury, shares         20,000us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
         
E.P. Marinos [Member]                    
Debt Instruments [Line Items]                    
Number of warrants issued 10,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
  10,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
             
Warrants unexercised 10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
  10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
             
Warrants                    
Debt Instruments [Line Items]                    
Issuance of common stock from treasury, shares         30,000us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued
/ us-gaap_ClassOfWarrantOrRightAxis
= us-gaap_WarrantMember
         
Term Debt And Equipment Notes [Member] | Equipment Term Loans [Member]                    
Debt Instruments [Line Items]                    
Number of equipment notes           2micr_NumberOfEquipmentNotes
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
       
Debt instrument, face amount           272,500us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
       
Debt instrument, interest rate 4.66%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
  4.66%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
             
Approximate monthly principal and interest payment     5,000us-gaap_DebtInstrumentPeriodicPayment
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
             
Equipment notes, maturity period     5 years              
Subordinated Debt [Member]                    
Debt Instruments [Line Items]                    
Debt instrument, face amount               450,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
Debt instrument, maturity date     Dec. 31, 2018              
Interest rate 10.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  10.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
          12.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
10.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
Period for first interest rate of debt instrument     2 years              
Payment on subordinated debt             50,000us-gaap_RepaymentsOfSubordinatedDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Number of investors in the private offering               7micr_NumberOfInvestorsInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
   
Number of investors, maturity date extended               6micr_NumberOfInvestorsMaturityDateExtended
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
   
Number of investors, maturity date not extended             1micr_NumberOfInvestorsMaturityDateNotExtended
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Debt, fair value 18,310us-gaap_LongTermDebtFairValue
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  18,310us-gaap_LongTermDebtFairValue
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
             
Percent of test for fair value     10.00%micr_PercentOfTestForFairValue
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
             
Unamortized discount 11,261us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  11,261us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
      17,989us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Subordinated Debt [Member] | REF Securities, LLP & Mr. Rodd E. Friedman [Member]                    
Debt Instruments [Line Items]                    
Percent of beneficial owner of company's common stock     13.00%micr_PercentOfBeneficialOwnerOfCompanySCommonStock
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
             
Invested amount in private offering     100,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
             
Subordinated Debt [Member] | Chambers Medical Foundation [Member]                    
Debt Instruments [Line Items]                    
Percent of beneficial owner of company's common stock     10.00%micr_PercentOfBeneficialOwnerOfCompanySCommonStock
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
             
Invested amount in private offering     100,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
             
Subordinated Debt [Member] | E.P. Marinos [Member]                    
Debt Instruments [Line Items]                    
Invested amount in private offering     50,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
             
Subordinated Debt [Member] | Three Related Parties [Member]                    
Debt Instruments [Line Items]                    
Debt instrument, face amount               $ 250,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ThreeRelatedPartiesMember
   

Debt (Summary of Debt) (Details)
v6.14.0.7
Debt (Summary of Debt) (Details) (USD $)
Sep. 30, 2017
Dec. 31, 2016
Debt Instrument [Line Items]    
Revolving line of credit $ 3,070,000us-gaap_LineOfCredit $ 1,785,795us-gaap_LineOfCredit
Equipment line of credit 504,781micr_EquipmentLineOfCredit 102,500micr_EquipmentLineOfCredit
Subordinated promissory notes 438,739us-gaap_SubordinatedDebt 432,011us-gaap_SubordinatedDebt
Total term notes payable 2,093,133us-gaap_DebtInstrumentCarryingAmount 2,458,331us-gaap_DebtInstrumentCarryingAmount
Total Debt 6,106,653us-gaap_DebtLongtermAndShorttermCombinedAmount 4,778,637us-gaap_DebtLongtermAndShorttermCombinedAmount
Term Debt And Equipment Notes [Member] | Commercial Term Loan [Member]    
Debt Instrument [Line Items]    
Total term notes payable 2,078,006us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
2,398,870us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
Term Debt And Equipment Notes [Member] | Equipment Notes [Member]    
Debt Instrument [Line Items]    
Total term notes payable $ 15,127us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentNotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
$ 59,461us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentNotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember

Income Taxes (Details)
v6.14.0.7
Income Taxes (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating Loss Carryforwards [Line Items]        
Income tax provision (benefit)            
Federal Tax Authority [Member]        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforwards 303,000us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_DomesticCountryMember
  303,000us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_DomesticCountryMember
 
State Jurisdiction [Member]        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforwards 357,000us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_StateAndLocalJurisdictionMember
  357,000us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_StateAndLocalJurisdictionMember
 
Federal Tax Authority [Member]        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 9,124,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember
  9,124,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember
 
State Jurisdiction [Member]        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards $ 8,196,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_StateAndLocalJurisdictionMember
  $ 8,196,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_StateAndLocalJurisdictionMember
 

Commitments and Contingencies (Details)
v6.14.0.7
Commitments and Contingencies (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Commitments and Contingencies [Abstract]        
Operating lease expense, office equipment $ 4,615us-gaap_LeaseAndRentalExpense $ 4,615us-gaap_LeaseAndRentalExpense $ 13,114us-gaap_LeaseAndRentalExpense $ 14,444us-gaap_LeaseAndRentalExpense

Shareholders' Equity (Narrative) (Details)
v6.14.0.7
Shareholders' Equity (Narrative) (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of options, granted in period 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross    5,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Number of options, expired in period 2,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod 2,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod  
Number of options, forfeited in period 3,000us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares 7,000us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares  
Number of options, exercised in period   0us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised    15,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Proceeds from stock options exercises       $ 51,150us-gaap_ProceedsFromStockOptionsExercised
Warrants exercised 0micr_WarrantsExercised 0micr_WarrantsExercised    
Warrants unexercised 70,000us-gaap_ClassOfWarrantOrRightOutstanding   70,000us-gaap_ClassOfWarrantOrRightOutstanding  
Common stock granted, shares 12,154us-gaap_StockIssuedDuringPeriodSharesNewIssues 0us-gaap_StockIssuedDuringPeriodSharesNewIssues 16,514us-gaap_StockIssuedDuringPeriodSharesNewIssues 0us-gaap_StockIssuedDuringPeriodSharesNewIssues
Common stock granted, values 47,250us-gaap_StockIssuedDuringPeriodValueNewIssues   58,500us-gaap_StockIssuedDuringPeriodValueNewIssues  
REF Securities, LLP & Mr. Rodd E. Friedman [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Warrants unexercised 20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
  20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
 
E.P. Marinos [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Warrants unexercised 10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
  10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
 
Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense $ 5,083us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
4,492us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
$ 26,250us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
$ 35,083us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember

Shareholders' Equity (Stock Option Transactions) (Details)
v6.14.0.7
Shareholders' Equity (Stock Option Transactions) (Details) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Shareholders' Equity [Abstract]          
Number of options, outstanding, beginning balance     214,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber    
Number of options, granted in period 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross    5,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross  
Number of options, exercised in period   0us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised    (15,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised  
Number of options, forfeited in period (3,000)us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares (7,000)us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares    
Number of options, expired in period (2,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod (2,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod    
Number of options, outstanding, ending balance 205,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber   205,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber   214,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Number of options, exercisable 115,495us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions   115,495us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions   109,495us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
Weighted average exercise price, outstanding, beginning of period     $ 5.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice    
Weighted average exercise price, options granted in period           
Weighted average exercise price, options exercised in period           
Weighted average exercise price, options forfeited in period     $ 4.26us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice    
Weighted average exercise price, options expired in period     $ 3.67us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice    
Weighted average exercise price, outstanding, ending of period $ 6.04us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice   $ 6.04us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice   $ 5.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Weighted average exercise price, options exercisable $ 6.88us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice   $ 6.88us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice   $ 6.90us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Weighted average remaining contractual term (in years), options outstanding     6 years 3 months 29 days   7 years 1 month 13 days
Weighted average remaining contractual term (in years), options exercisable     5 years 11 months 5 days   5 years 5 months 19 days
Aggregate intrinsic value, options outstanding $ 28,750us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue   $ 28,750us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue   $ 17,340us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
Aggregate intrinsic value, options exercisable $ 17,980us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue   $ 17,980us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue   $ 8,880us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue